BVF INC/IL - Stock Holdings in 13F Filings (SEC)
Updated on March 15, 2026.
Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, BVF INC/IL held in its portfolio 41 assets valued at $2,970,708,839 (i.e. $2.97B).
The most valuable assets in the portfolio included: KYMERA THERAPEUTICS INC ($428.17M), REVOLUTION MEDICINES INC ($267.37M), and MOONLAKE IMMUNOTHERAPEUTICS ($260.32M).
The chart below shows the top 10 valuable assets, and the table below shows the top 41 valuable assets.
You can see similar for other investment managers.
Related Topics: SEC Topic List.
Data Source: SEC.
BVF INC/IL - Stock Holdings in 13F Filings (SEC)
Items per page:
25
0 of 0
| Name of Issuer | No. of Shares | Value ($) | Class |
|---|---|---|---|
| KYMERA THERAPEUTICS INC | 5502710 | 428165865 | COM |
| REVOLUTION MEDICINES INC | 3356782 | 267367686 | COM |
| MOONLAKE IMMUNOTHERAPEUTICS | 19751284 | 260321923 | CLASS A ORD |
| STRUCTURE THERAPEUTICS INC | 3479022 | 241965980 | SPONSORED ADS |
| OLEMA PHARMACEUTICALS INC | 5295893 | 132397325 | COM |
| MIRUM PHARMACEUTICALS INC | 1495290 | 118112957 | COM |
| GH RESEARCH PLC | 8827712 | 112111942 | ORDINARY SHARES |
| XENCOR INC | 7133720 | 109217253 | COM |
| ZYMEWORKS INC | 3938641 | 103704418 | COM |
| PALVELLA THERAPEUTICS INC NE | 879009 | 92005872 | COM |
| KURA ONCOLOGY INC | 8617162 | 89532313 | COM |
| STOKE THERAPEUTICS INC | 2265674 | 71912493 | COM |
| XOMA ROYALTY CORPORATION | 2590303 | 68876157 | COM NEW |
| ABIVAX SA | 508031 | 68510521 | SPONSORED ADS |
| NEKTAR THERAPEUTICS | 1559595 | 65939677 | COM NEW |
| AC IMMUNE SA | 19822436 | 62242449 | SHS |
| MONTE ROSA THERAPEUTICS INC | 3835886 | 60146692 | COM |
| CULLINAN THERAPEUTICS INC | 5750683 | 59519569 | COM |
| TYRA BIOSCIENCES INC | 2127665 | 55936313 | COM |
| DISC MEDICINE INC | 650000 | 51616500 | COM |
| IMMUNOCORE HLDGS PLC | 1488975 | 50293922 | ADS |
| INVIVYD INC | 19525000 | 48226750 | COM |
| SEPTERNA INC | 1720782 | 47975402 | COM |
| ANNEXON INC | 9128080 | 45822962 | COM |
| COMPASS THERAPEUTICS INC | 7764842 | 41697202 | COM |
| 4D MOLECULAR THERAPEUTICS IN | 4629289 | 34719668 | COM |
| CRESCENT BIOPHARMA INC. | 2748763 | 32600329 | COM |
| FOGHORN THERAPEUTICS INC | 5302000 | 28630800 | COM |
| REPARE THERAPEUTICS INC | 10333600 | 26867360 | COM |
| AVALO THERAPEUTICS INC | 1355257 | 24611467 | COM NEW |
| PEPGEN INC | 1915000 | 12466650 | COM |
| ELEDON PHARMACEUTICALS INC | 6293282 | 9502856 | COM |
| X4 PHARMACEUTICALS INC | 2233742 | 8934968 | COM NEW |
| AXSOME THERAPEUTICS INC | 45757 | 8357058 | COM |
| MOLECULAR PARTNERS AG | 1353968 | 5822062 | ADS |
| IMAGENEBIO INC | 802102 | 5534504 | COM |
| TSCAN THERAPEUTICS INC | 5226074 | 5226074 | COM |
| TENAX THERAPEUTICS INC | 339549 | 4139102 | COM NEW |
| IMMUNIC INC | 7652972 | 4084391 | COM |
| INVENTIVA SA | 686040 | 3190086 | ADS |
| ENGENE HOLDINGS INC | 945402 | 2401321 | *W EXP 10/31/202 |